Analystreport

Taro Pharmaceutical Industries Ltd. (NYSE: TARO) had its price target lowered by analysts at HC Wainwright from $82.00 to $80.00. They now have a "buy" rating on the

Taro Pharmaceutical Industries Ltd. Ordinary Shares  (TARO) 
Last taro pharmaceutical industries ltd. ordinary shares earnings: 2/3 05:21 pm Check Earnings Report